Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of VGB-R04 in Adult Hemophilia B Patients [Phase 1, Phase 2]

View source ↗

Summary

A study evaluating the safety and efficacy of VGB-R04 in adults with Hemophilia B is currently in Phase 1/2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Drugs mentioned

• VGB-R04

Snippet

Sponsor: Shanghai Vitalgen BioPharma Co., Ltd. | Conditions: Hemophilia B | Phase 1, Phase 2 | Status: UNKNOWN